Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.
16 Feb 2021 | 04:00 pm |
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).
The transaction transfers ownership of the brand portfolio, comprised of Flux®, Decubal®, Lactocare®, Apobase®, Dailycare® and Fludent® from Teva to Karo. The transactionis is expected to close on April 1.
The Pinsent Masons team was jointly led by partners Allistair Booth and Thilo Schneider and included senior associate Ciaran Wilkinson.
Commenting on the transaction Thilo Schneider said:
"I am so pleased that we have been able to support Teva and to have brought this transaction to a successful conclusion. The sale is significant for both parties and we are proud to have achieved a successful outcome for Teva. We worked closely with them to understand what they wanted to achieve and helped to determine the best options available to them."
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises on landmark university merger
Multinational law firm Pinsent Masons has advised the University of Greenwich on the trailblazing merger with the University of Kent, paving the way for the creation of the UK’s first “super‑university”.
Pinsent Masons advises on sale of VLocker to Venu+
Multinational law firm Pinsent Masons has advised on the sale of VLocker, a global leader in the design, manufacture, installation and management of electronic locker systems, to Venu+, a United States‑based portfolio company of private equity fund ZCG.
Pinsent Masons launches in Poland
Multinational law firm Pinsent Masons is expanding its European footprint into Poland, announcing plans to open in Warsaw in mid-2026.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons announces FY24/25 results
Multinational law firm Pinsent Masons has today unveiled its unaudited financial results for the year ending 30 April 2025. This year's results have delivered a revenue increase of 4.7% after a year of continued growth within the firm’s core sectors and across its jurisdictions.
Pinsent Masons announces new leadership for Global IP Group and Life Sciences
Pinsent Masons has appointed Judith Krens (Partner, Amsterdam) and Tom Nener (Partner, Birmingham) as co-leads of the Global Intellectual Property (IP) team, and has appointed Charlotte Weekes (Partner, London) as Head of Life Sciences. The appointments come in light of the upcoming departure of Clare Tunstall, the current Head of IP and Life Sciences, who will be leaving the firm in the Autumn.
Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London
Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]